Bsorbance to 1 [27] and subtracting the MedChemExpress 301353-96-8 background absorbance arising from glycation-induced AGE formation on apoA-I.Table 2. Loss of Arg, Lys and Trp ( of controls) and CML formation 10781694 (nmol/mg protein) on glycated lipid-free apoA-I and drHDL.Arg Lipid-free apoA-I Control Glucose: 15 mM 30 mM Methylglyoxal: 1.5 mM 3 mM 15 mM 30 mM Glycolaldehyde: 0.3 mM 1.5 mM 3 mM 7.5 mM 15 mM 30 mM drHDL Control Glucose: 30 mM Methylglyoxal: 3 mM 30 mM Glycolaldehyde: 3 mM 30 mM 10068 10161 5961* 4962* 10261 9762 10065 10667 9064 67616* 5762* 4667* 4562* 9962 8964* 9363 9961 8868* 7662*LysTrpCML10066 9564 8762 71611* 6962* 4068* 4161* 9462 7368* 7661* 5662* 2768* 1363*10062 107615 8662 76611* 7361* 4469* 4862* 9761 77610* 7762* 4763* 1965* 1164*0.0260.01 ND ND ND ND ND ND 0.5860.04a 8.6160.40b 16.3360.06c 16.9864.53c 21.5062.71d 34.7260.84eCell studiesJ774A.1 murine macrophages (ATCC, TIB-67) were cultured and incubated with acetylated LDL (AcLDL, 200 mg apoB/ml, 24 h) as previously [9]. Cells were subsequently washed and incubated overnight in media containing BSA (0.2 w/v) and 8(4-chlorophenylthio)adenosine 39,59-cyclic monohydrate phosphate (cAMP; 0.3 mM) [29]. For the drHDL experiments, cells were incubated 65 mM 9-cis-retinoic acid and TO-901317 (N(2,2,2-trifluoro-ethyl)-N-[4-(2,2,2-tri- fluoro- 1-hydroxy-1-trifluoromethyl-ethyl)-phenyl]- benzenesulfonamide; Sigma-Aldrich, St. Louis, USA) [13]. Cells were then washed and exposed to media containing BSA (0.2 w/v) for up to 8 h without or with 50 mg protein/ml apoA-I or drHDL to induce efflux. Media was collected as indicated, and the cells washed prior to lysis in water. Media and lysates were analysed for cholesterol and cholesteryl esters by HPLC [9]. Cell viability and number were determined by lactate dehydrogenase (LDH) release and protein concentrations respectively [9].10061 9663 7563* 5163* 8361* 1862*10061 9565 8663* 6261* 9663 1963*ND ND ND ND ND NDData are expressed relative to control apoA-I (16 Arg, 21 Lys, 4 Trp). *Significantly different to 0 mM (one-way ANOVA). Statistical differences for CML data (one-way ANOVA): a versus control; b versus control and 0.3 mM glycolaldehyde; c versus control, 0.3 and 1.5 mM glycolaldehyde; d versus control, 0.3, 1.5 and 3 mM glycolaldehyde; e versus control, 0.3,1.5, 3, 7.5 and 15 mM glycolaldehyde. ND, not determined. doi:10.1371/journal.pone.0065430.tStatistical AnalysisData are mean 6 SD from at least three independent experiments each with triplicate samples. Statistical analysis was performed by two-tailed t-test, or one-way or two-way ANOVA and Tukey’s post hoc analysis; p,0.05 was taken as statistically significant. apoA-I for the same concentration of aldehyde (e.g. lane 6 versus lane 10, Fig. 1A). drHDL composition or particle size were not affected by glycolaldehyde (data not shown). 370-86-5 chemical information Methylglyoxal did not alter drHDL composition, but induced a small decrease in particle diameter (9.7 to 9.0 nm) at high concentrations [15].Results Characterisation of in vitro glycated lipid-free apoA-I and drHDLGlucose (0?0 mM) did not induce significant Arg, Lys and Trp loss from either lipid-free apoA-I or drHDL (Table 2) consistent with insignificant levels of glycation and/or oxidation of these materials. In contrast, methylglyoxal and glycolaldehyde induced significant concentration-dependent losses. Arg loss was more extensive with methylglyoxal, whereas Lys and Trp loss was more marked with glycolaldehyde (Table 2). Glycolaldehyde induced CML form.Bsorbance to 1 [27] and subtracting the background absorbance arising from glycation-induced AGE formation on apoA-I.Table 2. Loss of Arg, Lys and Trp ( of controls) and CML formation 10781694 (nmol/mg protein) on glycated lipid-free apoA-I and drHDL.Arg Lipid-free apoA-I Control Glucose: 15 mM 30 mM Methylglyoxal: 1.5 mM 3 mM 15 mM 30 mM Glycolaldehyde: 0.3 mM 1.5 mM 3 mM 7.5 mM 15 mM 30 mM drHDL Control Glucose: 30 mM Methylglyoxal: 3 mM 30 mM Glycolaldehyde: 3 mM 30 mM 10068 10161 5961* 4962* 10261 9762 10065 10667 9064 67616* 5762* 4667* 4562* 9962 8964* 9363 9961 8868* 7662*LysTrpCML10066 9564 8762 71611* 6962* 4068* 4161* 9462 7368* 7661* 5662* 2768* 1363*10062 107615 8662 76611* 7361* 4469* 4862* 9761 77610* 7762* 4763* 1965* 1164*0.0260.01 ND ND ND ND ND ND 0.5860.04a 8.6160.40b 16.3360.06c 16.9864.53c 21.5062.71d 34.7260.84eCell studiesJ774A.1 murine macrophages (ATCC, TIB-67) were cultured and incubated with acetylated LDL (AcLDL, 200 mg apoB/ml, 24 h) as previously [9]. Cells were subsequently washed and incubated overnight in media containing BSA (0.2 w/v) and 8(4-chlorophenylthio)adenosine 39,59-cyclic monohydrate phosphate (cAMP; 0.3 mM) [29]. For the drHDL experiments, cells were incubated 65 mM 9-cis-retinoic acid and TO-901317 (N(2,2,2-trifluoro-ethyl)-N-[4-(2,2,2-tri- fluoro- 1-hydroxy-1-trifluoromethyl-ethyl)-phenyl]- benzenesulfonamide; Sigma-Aldrich, St. Louis, USA) [13]. Cells were then washed and exposed to media containing BSA (0.2 w/v) for up to 8 h without or with 50 mg protein/ml apoA-I or drHDL to induce efflux. Media was collected as indicated, and the cells washed prior to lysis in water. Media and lysates were analysed for cholesterol and cholesteryl esters by HPLC [9]. Cell viability and number were determined by lactate dehydrogenase (LDH) release and protein concentrations respectively [9].10061 9663 7563* 5163* 8361* 1862*10061 9565 8663* 6261* 9663 1963*ND ND ND ND ND NDData are expressed relative to control apoA-I (16 Arg, 21 Lys, 4 Trp). *Significantly different to 0 mM (one-way ANOVA). Statistical differences for CML data (one-way ANOVA): a versus control; b versus control and 0.3 mM glycolaldehyde; c versus control, 0.3 and 1.5 mM glycolaldehyde; d versus control, 0.3, 1.5 and 3 mM glycolaldehyde; e versus control, 0.3,1.5, 3, 7.5 and 15 mM glycolaldehyde. ND, not determined. doi:10.1371/journal.pone.0065430.tStatistical AnalysisData are mean 6 SD from at least three independent experiments each with triplicate samples. Statistical analysis was performed by two-tailed t-test, or one-way or two-way ANOVA and Tukey’s post hoc analysis; p,0.05 was taken as statistically significant. apoA-I for the same concentration of aldehyde (e.g. lane 6 versus lane 10, Fig. 1A). drHDL composition or particle size were not affected by glycolaldehyde (data not shown). Methylglyoxal did not alter drHDL composition, but induced a small decrease in particle diameter (9.7 to 9.0 nm) at high concentrations [15].Results Characterisation of in vitro glycated lipid-free apoA-I and drHDLGlucose (0?0 mM) did not induce significant Arg, Lys and Trp loss from either lipid-free apoA-I or drHDL (Table 2) consistent with insignificant levels of glycation and/or oxidation of these materials. In contrast, methylglyoxal and glycolaldehyde induced significant concentration-dependent losses. Arg loss was more extensive with methylglyoxal, whereas Lys and Trp loss was more marked with glycolaldehyde (Table 2). Glycolaldehyde induced CML form.
